BOUNDLESS BIO, INC. Increase Decrease In Operating Lease Liability
BOUNDLESS BIO, INC. (BOLD) reported Increase Decrease In Operating Lease Liability of -$12.44 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-07
- BOUNDLESS BIO, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$11.69M, a 1349.04% decline year-over-year.
- BOUNDLESS BIO, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$747.00K, a 179.30% decline year-over-year.
- BOUNDLESS BIO, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$715.00K.
- BOUNDLESS BIO, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was $333.00K.
- BOUNDLESS BIO, INC. increase decrease in operating lease liability for fiscal 2025 was $1.50M.
- BOUNDLESS BIO, INC. increase decrease in operating lease liability for fiscal 2024 was -$2.15M.
- BOUNDLESS BIO, INC. increase decrease in operating lease liability for fiscal 2023 was -$2.55M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$11.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$12.44M 10-Q · filed 2026-08-07 | -$13.15M derived: sum of 3 quarters · filed 2026-08-07 | -$12.82M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$747.00K 10-Q · filed 2026-05-08 | -$1.46M derived: sum of 2 quarters · filed 2026-05-08 | -$1.13M derived: sum of 3 quarters · filed 2026-05-08 | -$193.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$715.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$382.00K derived: sum of 2 quarters · filed 2026-03-09 | $554.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.50M 10-K · filed 2026-03-09 |
| 2025-09-30 | $333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.27M derived: sum of 2 quarters · filed 2026-08-07 | $2.21M 10-Q · filed 2025-11-05 | $2.13M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $936.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.88M 10-Q · filed 2026-08-07 | $1.80M derived: sum of 3 quarters · filed 2026-08-07 | $1.08M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $942.00K 10-Q · filed 2026-05-08 | $865.00K derived: sum of 2 quarters · filed 2026-05-08 | $149.00K derived: sum of 3 quarters · filed 2026-05-08 | -$537.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$793.00K derived: sum of 2 quarters · filed 2026-03-09 | -$1.48M derived: sum of 3 quarters · filed 2026-03-09 | -$2.15M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$716.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.40M derived: sum of 2 quarters · filed 2025-11-05 | -$2.07M 10-Q · filed 2025-11-05 | -$2.89M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$686.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$1.36M 10-Q · filed 2025-08-05 | -$2.17M derived: sum of 3 quarters · filed 2025-08-05 | -$2.83M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$672.00K 10-Q · filed 2025-05-09 | -$1.49M derived: sum of 2 quarters · filed 2025-05-09 | -$2.15M derived: sum of 3 quarters · filed 2025-05-09 | -$2.68M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$816.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$1.47M derived: sum of 2 quarters · filed 2025-03-27 | -$2.01M derived: sum of 3 quarters · filed 2025-03-27 | -$2.55M 10-K · filed 2025-03-27 |
| 2023-09-30 | -$657.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.20M derived: sum of 2 quarters · filed 2024-11-07 | -$1.73M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$539.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$1.07M 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | -$535.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |